In a ruling announced on Thursday, France's Constitutional Council has approved government plans to introduce further restrictions over the Covid-19 epidemic, including the requirement that people display a vaccination or negative test 'health pass' before entering public venues, and the obligation for healthcare staff to be fully vaccinated.
The new legislation will provide access to various fertility procedures, notably in vitro fertilisation (IVF) and artificial insemination, for all women under 43, with costs covered by the French health service.
An anti Covid-19 vaccine developed by US pharma firm Pfizer and Germany's BioNTech has been approved for use in France by the country's top health authority, the Haute Autorité de la santé (HAS), with vaccinations due to start on a voluntazry basis on Sunday, with a priority given for those most at risk.
Air France pilots have approved a plan by the airline to launch a sub-brand called 'Boost' this September, which will offer long- and short-haul services that are cheaper than the parent carrier in an effort to counter competition from Gulf airlines and budget services by Lufthansa and British Airways.
French utilities giant EDF, which will build the controversial new nuclear power station extension in south-west England, greeted the news as "the relaunch of nuclear in Europe”.
Actionnaires directs et indirects : Société pour l’Indépendance de Mediapart, Fonds pour une Presse Libre, Association pour le droit de savoir
Rédaction et administration : 127 avenue Ledru-Rollin, 75011 Paris
Courriel : contact@mediapart.fr
Téléphone : + 33 (0) 1 44 68 99 08
Propriétaire, éditeur, imprimeur : Société Editrice de Mediapart
Abonnement : pour toute information, question ou conseil, le service abonnés de Mediapart peut être contacté par courriel à l’adresse : serviceabonnement@mediapart.fr ou par courrier à l'adresse : Service abonnés Mediapart, 11 place Charles de Gaulle 86000 Poitiers. Vous pouvez également adresser vos courriers à Société Editrice de Mediapart, 127 avenue Ledru-Rollin, 75011 Paris.
